523 related articles for article (PubMed ID: 26315378)
21. Mutation genotypes of RNF213 gene from moyamoya patients in Taiwan.
Lee MJ; Chen YF; Fan PC; Wang KC; Wang K; Wang J; Kuo MF
J Neurol Sci; 2015; 353(1-2):161-5. PubMed ID: 25956231
[TBL] [Abstract][Full Text] [Related]
22. Frequency of the moyamoya-related RNF213 p.Arg4810Lys variant in 1,516 Korean individuals.
Jang MA; Shin S; Yoon JH; Ki CS
BMC Med Genet; 2015 Nov; 16():109. PubMed ID: 26590131
[TBL] [Abstract][Full Text] [Related]
23. Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease.
Miyatake S; Miyake N; Touho H; Nishimura-Tadaki A; Kondo Y; Okada I; Tsurusaki Y; Doi H; Sakai H; Saitsu H; Shimojima K; Yamamoto T; Higurashi M; Kawahara N; Kawauchi H; Nagasaka K; Okamoto N; Mori T; Koyano S; Kuroiwa Y; Taguri M; Morita S; Matsubara Y; Kure S; Matsumoto N
Neurology; 2012 Mar; 78(11):803-10. PubMed ID: 22377813
[TBL] [Abstract][Full Text] [Related]
24. RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance.
Zhang Q; Liu Y; Zhang D; Wang R; Zhang Y; Wang S; Yu L; Lu C; Liu F; Zhou J; Zhang X; Zhao J
J Neurosurg; 2017 Apr; 126(4):1106-1113. PubMed ID: 27128593
[TBL] [Abstract][Full Text] [Related]
25. Moyamoya disease patient mutations in the RING domain of RNF213 reduce its ubiquitin ligase activity and enhance NFκB activation and apoptosis in an AAA+ domain-dependent manner.
Takeda M; Tezuka T; Kim M; Choi J; Oichi Y; Kobayashi H; Harada KH; Mizushima T; Taketani S; Koizumi A; Youssefian S
Biochem Biophys Res Commun; 2020 May; 525(3):668-674. PubMed ID: 32139119
[TBL] [Abstract][Full Text] [Related]
26. [Precision Medicine for Moyamoya Disease].
Fujimura M
No Shinkei Geka; 2022 Jan; 50(1):216-221. PubMed ID: 35169101
[TBL] [Abstract][Full Text] [Related]
27. RNF213 p.R4810K Polymorphism and the Risk of Moyamoya Disease, Intracranial Major Artery Stenosis/Occlusion, and Quasi-Moyamoya Disease: A Meta-Analysis.
Wang Y; Mambiya M; Li Q; Yang L; Jia H; Han Y; Liu W
J Stroke Cerebrovasc Dis; 2018 Aug; 27(8):2259-2270. PubMed ID: 29752070
[TBL] [Abstract][Full Text] [Related]
28. Frequency and significance of rare RNF213 variants in patients with adult moyamoya disease.
Jang MA; Chung JW; Yeon JY; Kim JS; Hong SC; Bang OY; Ki CS
PLoS One; 2017; 12(6):e0179689. PubMed ID: 28617845
[TBL] [Abstract][Full Text] [Related]
29. Reversible Cerebral Angiopathy after Viral Infection in a Pediatric Patient with Genetic Variant of RNF213.
Echizenya I; Tokairin K; Kawabori M; Kazumata K; Houkin K
J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104549. PubMed ID: 31818681
[TBL] [Abstract][Full Text] [Related]
30. Moyamoya disease susceptibility gene RNF213 links inflammatory and angiogenic signals in endothelial cells.
Ohkubo K; Sakai Y; Inoue H; Akamine S; Ishizaki Y; Matsushita Y; Sanefuji M; Torisu H; Ihara K; Sardiello M; Hara T
Sci Rep; 2015 Aug; 5():13191. PubMed ID: 26278786
[TBL] [Abstract][Full Text] [Related]
31. The Clinical and Vascular Characteristics of RNF213 c.14576G>A Variant-Related Intracranial Major Artery Disease in China.
Cheng W; Xue S; Wu F; Song X; Huang Q; Song H; Wu J
Behav Neurol; 2019; 2019():7908392. PubMed ID: 30992731
[TBL] [Abstract][Full Text] [Related]
32. RNF213 polymorphism and Moyamoya disease: A systematic review and meta-analysis.
Ma J; Liu Y; Ma L; Huang S; Li H; You C
Neurol India; 2013; 61(1):35-9. PubMed ID: 23466837
[TBL] [Abstract][Full Text] [Related]
33. RNF213 rare variants in an ethnically diverse population with Moyamoya disease.
Cecchi AC; Guo D; Ren Z; Flynn K; Santos-Cortez RL; Leal SM; Wang GT; Regalado ES; Steinberg GK; Shendure J; Bamshad MJ; ; Grotta JC; Nickerson DA; Pannu H; Milewicz DM
Stroke; 2014 Nov; 45(11):3200-7. PubMed ID: 25278557
[TBL] [Abstract][Full Text] [Related]
34. Impact of RNF213 c.14576G>A Variant on the Development of Direct and Indirect Revascularization in Pediatric Moyamoya Disease.
Kawabori M; Ito M; Kazumata K; Tokairin K; Hatanaka KC; Ishikawa S; Houkin K; Fujimura M
Cerebrovasc Dis; 2023; 52(2):171-176. PubMed ID: 36063804
[TBL] [Abstract][Full Text] [Related]
35. Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population.
Wu Z; Jiang H; Zhang L; Xu X; Zhang X; Kang Z; Song D; Zhang J; Guan M; Gu Y
PLoS One; 2012; 7(10):e48179. PubMed ID: 23110205
[TBL] [Abstract][Full Text] [Related]
36. Moyamoya Disease and Spectrums of RNF213 Vasculopathy.
Bang OY; Chung JW; Kim DH; Won HH; Yeon JY; Ki CS; Shin HJ; Kim JS; Hong SC; Kim DK; Koizumi A
Transl Stroke Res; 2020 Aug; 11(4):580-589. PubMed ID: 31650369
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of Securin by the variant RNF213 R4810K (rs112735431, G>A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients.
Hitomi T; Habu T; Kobayashi H; Okuda H; Harada KH; Osafune K; Taura D; Sone M; Asaka I; Ameku T; Watanabe A; Kasahara T; Sudo T; Shiota F; Hashikata H; Takagi Y; Morito D; Miyamoto S; Nakao K; Koizumi A
Biochem Biophys Res Commun; 2013 Aug; 438(1):13-9. PubMed ID: 23850618
[TBL] [Abstract][Full Text] [Related]
38. A Polymorphism in RNF213 Is a Susceptibility Gene for Intracranial Atherosclerosis.
Bang OY; Chung JW; Cha J; Lee MJ; Yeon JY; Ki CS; Jeon P; Kim JS; Hong SC
PLoS One; 2016; 11(6):e0156607. PubMed ID: 27253870
[TBL] [Abstract][Full Text] [Related]
39. De Novo Development of Moyamoya Disease in an Adult Female with a Genetic Variant of the RNF-213 Gene: Case Report.
Tashiro R; Fujimura M; Niizuma K; Endo H; Sakata H; Sato-Maeda M; Tominaga T
J Stroke Cerebrovasc Dis; 2017 Jan; 26(1):e8-e11. PubMed ID: 27789153
[TBL] [Abstract][Full Text] [Related]
40. Moyamoya disease factor RNF213 is a giant E3 ligase with a dynein-like core and a distinct ubiquitin-transfer mechanism.
Ahel J; Lehner A; Vogel A; Schleiffer A; Meinhart A; Haselbach D; Clausen T
Elife; 2020 Jun; 9():. PubMed ID: 32573437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
